News
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...
China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...
13h
ThePrint on MSNBlockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunityPharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...
Health officials have issued yet another warning over the perils of fake weight loss jabs after an influencer nearly died ...
Gibbs puts a patient's volume of food noise down to a mix of genetics, environment, socialisation and food availability. Too ...
Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine ...
Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 ...
Over time, these drugs have also been found to help people lose weight by slowing digestion, reducing hunger, and making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results